Los Angeles Capital Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,632	Closed	-$245K	–	1440
2022 Q1	$245K	Sell	6,632 -422	-6%	-$15.6K	﹤0.01%	1311
2021 Q4	$690K	Buy	7,054 +6,433	+1,036%	+$629K	﹤0.01%	865
2021 Q3	$78K	Buy	621 +262	+73%	+$32.9K	﹤0.01%	1456
2021 Q2	$45K	Buy	+359	New	+$45K	﹤0.01%	1517